|
CADASIL
|
C10.228.140.300.400.203 |
|
|
Dementia, Vascular
|
C10.228.140.300.400 |
|
|
Radioisotopes
|
D011868 |
[Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
] |
|
Radioligand Assay
|
D011869 |
[Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders).
] |
|
HLA-DR alpha-Chains
|
D059805 |
[Transmembrane proteins that form the alpha subunits of the HLA-DR antigens. They are also referred to as the HLA-DR heavy chains.
] |
|
HLA-DR beta-Chains
|
D059806 |
[Transmembrane proteins that form the beta subunits of the HLA-DR antigens. They are also referred to as the HLA-DR light chains.
] |
|
S Phase Cell Cycle Checkpoints
|
D059807 |
[Cell regulatory signaling system that controls progression through S PHASE and stabilizes the replication forks during conditions that could affect the fidelity of DNA REPLICATION, such as DNA DAMAGE or depletion of nucleotide pools.
] |
|
Flurogestone Acetate
|
D04.210.500.908.550 |
|
|
Rapamycin-Insensitive Companion of mTOR Protein
|
D12.776.157.057.156 |
|
|
Regulatory-Associated Protein of mTOR
|
D12.776.157.057.157 |
|
|
Radiography, Abdominal
|
D011860 |
[Radiographic visualization of the body between the thorax and the pelvis, i.e., within the peritoneal cavity.
] |
|
Radiography, Dental
|
D011861 |
[Radiographic techniques used in dentistry.
] |
|
Proto-Oncogene Proteins c-vav
|
D12.776.157.057.155 |
|
|
Cytochrome P-450 CYP1A2 Inhibitors
|
D27.505.389.500.120 |
|
|
Health Facility Size
|
N02.278.306 |
|
|
Aminopyridines
|
D02.092.080 |
|
|
Inert Gas Narcosis
|
C25.723.455.571 |
|
|
Receptors, Adrenergic, alpha
|
D12.776.543.750.720.330.300.300 |
|
|
Xeromammography
|
E01.370.350.700.975.975 |
|
|
Phosphotungstic Acid
|
D01.029.260.700.675.750 |
|
